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Some studies reported that, in polymicrobial consortia, some P. aeruginosa exoproducts 
suppresses the growth of S. aureus and provokes the emergence of SCV, associated with 
antimicrobial resistance, altered metabolism and reduced immunogenicity. However, the 
role of S.aureus in P.aerugionsa behavior has still not been deciphered. 
This work aimed to deeply investigate the phenotypic changes undergone by P. aeruginosa 
and S. aureus in a co-infection scenario. The cells recovered from 24-h-old single and dual-
species biofilms were inspected regarding their colony morphology differentiation, 
antibiotic susceptibility profiles and expression of virulence factors. 
The population analysis profiles showed the existence of two P.aeruginosa SCV resulting 
only from the dual-species biofilms. These SCV exhibited impressive ability to form biofilm, 
impaired swimming, twitching and swarming abilities, in comparison with the wild-type 
morphotype. Their morphologies remained unchangeable over 10 passages onto solid 
media, which may mean these phenotypic alterations were not adaptive. Yet, the two SCV 
were susceptible to the action of several classes of antibiotics. 
In conclusion, the presence of S.aureus in biofilms seemed to modulate some phenotypic 
alterations in P.aeruginosa that may be clinically relevant as two SCV were detected. As the 
role of S. aureus over P. aeruginosa stills not full clear, some tests are being run to more 
comprehensively know how these P. aeruginosa SCV modulate the dual-species community 
response to in-use antimicrobials.   
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